Nurtec ODT 75 MG tablet 8S
Ended Awarded
- Contract number
- SPE2DB25FBKG6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,700
Award facts
- Contract value 100% obligated
- $47,700.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for NURTEC ODT 75 mg tablets (8-count packages) valued at $47,700.18. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without any set-aside designation. This award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion prime vendor agreement running through December 2026 that authorizes the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally.
The delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare systems. NURTEC ODT (ubrogepant) is a migraine treatment medication, reflecting AmerisourceBergen's ongoing role in supplying specialized neurological and pain management pharmaceuticals to military and veteran healthcare networks. The company's extensive portfolio of federal contract awards demonstrates its established capability to fulfill federal procurement requirements across diverse therapeutic domains, including diabetes medications, neurological treatments, vaccines, and medical devices. This competitive award underscores AmerisourceBergen's position as a critical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FBKG6?
SPE2DB25FBKG6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FBKG6 worth?
The government has obligated $47,700 on SPE2DB25FBKG6.
Is contract SPE2DB25FBKG6 an order under another contract?
Yes. SPE2DB25FBKG6 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBKG6 competed?
The extent of competition for SPE2DB25FBKG6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award